MOBOCERTINIB vs MOGAMULIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
MOBOCERTINIB vs MOGAMULIZUMAB: Safety Overview
| Metric | MOBOCERTINIB | MOGAMULIZUMAB |
|---|---|---|
| Total FAERS Reports | 715 | 441 |
| Deaths Reported | 320 | 128 |
| Death Rate | 44.8% | 29.0% |
| Hospitalizations | 227 | 181 |
| Average Patient Age | 65.7 yrs | 64.5 yrs |
| % Female Patients | 66.1% | 38.1% |
| FDA Approval Date | Sep 15, 2021 | N/A |
| Manufacturer | N/A | Kyowa Kirin, Inc. |
| Route | N/A | INTRAVENOUS |
| Marketing Status | Discontinued | N/A |